EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Evaluation of Retrospective Fusion of SPECT and MRI in Back Pain: A Pilot Study

Arman Parsai, Imene Zerizer, Hikmat Jan, Adrian Kastler, Eushaa Mirza, Marc E. Miquel

Clinical Nuclear Medicine Open · 2025

DOI: 10.1097/nm9.0000000000000026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Nuclear Medicine Open, 2025. Verfasst von Arman Parsai und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Not applicable.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

MRI is the preferred spinal imaging modality, but lacks metabolic information, while SPECT/CT provides functional information on osteoblastic activity. We aimed to determine if retrospective fusion of SPECT and MRI (SPECT/MRI) enhances disease site identification and reader confidence compared with SPECT/CT or MRI in chronic back pain refractory to medical management.

Methods

One hundred and eighteen patients with chronic back pain not responding to medical management and investigated with MRI and SPECT/CT were selected. Two readers compared SPECT/MRI images to sequential reviews of SPECT/CT and MRI, MRI, and SPECT/CT alone. Potential pain generator sites and diagnostic confidence for each modality were recorded. New findings on SPECT/MRI were reviewed at a multidisciplinary meeting (MDM), and potential management changes were recorded.

Results

Diagnostic confidence for SPECT/MRI (4.99) was higher than sequential SPECT/CT and MRI (3.8), MRI (3.6), or SPECT/CT (3). SPECT/MRI did not detect new disc disease, but found more sites (1%) in patients with known disc disease compared with other modalities. SPECT/MRI detected more patients and sites of endplate and facet disease compared with other modalities. It found 25% more patients and 49.5% more sites for endplate disease; 31.3% more patients and 46.7% more sites for facet disease compared with sequential review of SPECT/CT and MRI. The MDM review did not change the management for new disc disease sites. However, in 19 (25.6%) patients with new endplate disease, 45 (38.1%) patients with additional endplate disease, 20 (16.9%) patients with new facet disease, and 45 (38.1%) patients with additional facet disease, management changes were adopted.

Conclusions

SPECT/MRI in refractory back pain detects additional disc, endplate, and facet disease sites and new patients compared with sequential SPECT/CT, MRI, or SPECT/CT alone, potentially leading to management changes.

Förderung

  • Not applicable

Zitieren

APA

Parsai, A., Zerizer, I., Jan, H., Kastler, A., Mirza, E., & Miquel, M. E. (2025). Evaluation of Retrospective Fusion of SPECT and MRI in Back Pain: A Pilot Study. Clinical Nuclear Medicine Open. https://doi.org/10.1097/nm9.0000000000000026

Vancouver

Parsai A, Zerizer I, Jan H, Kastler A, Mirza E, Miquel ME. Evaluation of Retrospective Fusion of SPECT and MRI in Back Pain: A Pilot Study. Clinical Nuclear Medicine Open. 2025. doi:10.1097/nm9.0000000000000026

BibTeX
@article{Parsai2025,
  author = {Parsai, Arman and Zerizer, Imene and Jan, Hikmat and Kastler, Adrian and Mirza, Eushaa and Miquel, Marc E.},
  title = {Evaluation of Retrospective Fusion of SPECT and MRI in Back Pain: A Pilot Study},
  journal = {Clinical Nuclear Medicine Open},
  year = {2025},
  doi = {10.1097/nm9.0000000000000026}
}
Kostenlos starten →